With its shares having reached 25.75p last week and closed at above 25p on Wednesday, Amryt Pharma (AMYT) announced on Thursday that it was “delighted with the support we have received” for an “oversubscribed placing”, raising a gross €15 million (£13.3 million)… at 20p per share! As a long standing shareholder I say "F**k you." I feel so utterly 100% shafted as will those who paid 26p+ last week after confident results which made it clear that Amryt was fully funded. So I asked Steve Moore to pen an analysis. As I explained in Thursday's bearcast HERE I am too angry to be objective. The fact is that at a 22.5p offer the shares are a BUY.
on ShareProphets | Comments